Contact
searchSearch
HMP Global

*CANCELED* ACC.20 Together With World Congress of Cardiology (ACC.20/WCC)

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

Intravascular Lithotripsy
AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study
05/21/2026
BOSTON--Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, announced the enrollment of the first patient in its first-in-human (FIH) study for...
BOSTON--Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, announced the enrollment of the first patient in its first-in-human (FIH) study for...
BOSTON--Amplitude Vascular...
05/21/2026
Cath Lab Digest
Stent Clinical Trials
Reflow Medical Reports Six-Month Results from DEEPER CORONARY Study of Spur® Elute Stent
05/20/2026
DEEPER CORONARY is a first-in-human pilot study designed to evaluate the short-term safety of the investigational coronary Spur Elute System as a primary treatment for coronary ISR.
DEEPER CORONARY is a first-in-human pilot study designed to evaluate the short-term safety of the investigational coronary Spur Elute System as a primary treatment for coronary ISR.
DEEPER CORONARY is a...
05/20/2026
Cath Lab Digest
Head-to-Head Trials
SMART Trial Three-Year Data Demonstrate Superior Benefits With Evolut TAVR™ System
05/20/2026
EuroPCR Hot Line Science features positive outcomes from the largest international head-to-head comparative trial of TAVR.
EuroPCR Hot Line Science features positive outcomes from the largest international head-to-head comparative trial of TAVR.
EuroPCR Hot Line Science...
05/20/2026
Cath Lab Digest
Thrombectomy
Endologix Acquires Pounce™ Thrombectomy System, Expanding Its Vascular Intervention Portfolio
05/20/2026
SANTA ROSA, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™...
SANTA ROSA, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™...
SANTA ROSA, Calif.--(BUSINESS...
05/20/2026
Vascular Disease Management
IVL Clinical Trial
Shockwave Medical Study Confirms Benefit of IVL-First Strategy in Real-World Female Patients with Complex Calcified Lesions in Late-Breaking Data Presentation at EuroPCR 2025
05/19/2026
EMPOWER CAD, a global prospective, multi-center, real-world study, reaffirms favorable acute outcomes for coronary IVL in female patients, unlike other calcium modification tools.
EMPOWER CAD, a global prospective, multi-center, real-world study, reaffirms favorable acute outcomes for coronary IVL in female patients, unlike other calcium modification tools.
EMPOWER CAD, a global...
05/19/2026
Cath Lab Digest
Intravascular Lithotripsy
Cagent Vascular Reports First Human Use of Serranator® SONIC IVL System and Closes Oversubscribed $41M Series D Financing
05/19/2026
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development.
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development.
Financing supports clinical...
05/19/2026
Vascular Disease Management
IVL Clinical Trial
FRACTURE IDE Trial of Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter Meets Primary Safety and Effectiveness Endpoints
05/19/2026
Late-breaking data from global pivotal study achieved high rates of freedom from major adverse cardiac events and procedural success in patients with severe coronary artery disease.
Late-breaking data from global pivotal study achieved high rates of freedom from major adverse cardiac events and procedural success in patients with severe coronary artery disease.
Late-breaking data from global...
05/19/2026
Cath Lab Digest
Intravascular Lithotripsy
FastWave Medical Secures Four New International Patents
05/19/2026
Newly issued patents in Australia and Japan cover the company's Artero™ E-IVL and Sola™ L-IVL platforms as FastWave advances toward peripheral and coronary IDE trials.
Newly issued patents in Australia and Japan cover the company's Artero™ E-IVL and Sola™ L-IVL platforms as FastWave advances toward peripheral and coronary IDE trials.
Newly issued patents in...
05/19/2026
Cath Lab Digest
Heart Failure Devices
WhiteSwell Announces Primary Clinical Trial Results of DELTA-HF Study in Acute Decompensated Heart Failure
05/14/2026
The eLym System is an investigational catheter-based device for treating patients with acute decompensated heart failure (ADHF) by supporting lymphatic drainage.
The eLym System is an investigational catheter-based device for treating patients with acute decompensated heart failure (ADHF) by supporting lymphatic drainage.
The eLym System is an...
05/14/2026
Cath Lab Digest
Uncontrolled Hypertension
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
05/13/2026
Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026    Orchestra BioMed and Medtronic plc, the Company’s strategic collaborator for the BACKBEAT Trial,...
Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026    Orchestra BioMed and Medtronic plc, the Company’s strategic collaborator for the BACKBEAT Trial,...
Orchestra BioMed targeting...
05/13/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use